The dilemma of patients with a rising PSA level after definitive local therapy for prostate cancer

Seminars in Urologic Oncology

Volumn 20, Issue 2, 2002, Pages 146-154

  Lassiter, Lance K ^a   Eisenberger, Mario A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Biochemical recurrence; Nomogram; Prostate cancer; PSA; PSA doubling time

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 0036097508     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.32834     Document Type: Article

References (32)

1. Cancer statistics, 2002
2. Natural history of progression after PSA elevation following radical prostatectomy
3. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer
4. Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy
5. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer
6. Current follow up strategies after radical prostatectomy: A survey of American Urological Association urologists
7. Management of patients with rising prostate-specific antigen after radical prostatectomy
8. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer
9. Rising PSA after a radical treatment
10. The management of prostate cancer in patients with a rising prostate-specific antigen level
11. Consensus statement: Guidelines for PSA following radiation therapy
12. A catalog of prostate cancer nomograms
13. 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer
14. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control
15. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy
16. Radical prostatectomy: Transrectal sonographic evaluation to assess for local recurrence
17. Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy
18. Prostate-specific membrane antigen (PSMA): Current benefits and future value
19. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy
20. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy
21. 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy
22. Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer
23. ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: Analysis of 136 scans of 100 patients
24. Cancer control with radical prostatectomy alone in 1,000 consecutive patients
25. Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy
26. Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen
27. Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: Correlation with histologic characteristics of the primary cancer
28. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations
29. The PSA nadir that indicates potential cure after radiotherapy for prostate cancer
30. Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy
31. Patterns and fate of PSA bouncing following 3D-CRT